Recent publications showed that Ezrin is strongly expressed in a variety of invasive cancers, including osteosarcoma, melanoma, soft tissue sarcoma, pancreatic carcinoma, hepatocellular carcinoma and gastric and breast cancers[2,11-17]. The gene discussed is EZR; the disease is exocrine pancreatic carcinoma.